Press Releases
Your resource for the latest Grifols news. You can search all published press releases by year and news category, or by using the search bar below.
Showing 202 search results
GigaGen Doses First Patient in Phase 1 Trial of Recombinant Polyclonal Drug Candidate, GIGA-2339, for Hepatitis B Virus
Grifols Delivers Strong Third-Quarter Performance Led by Biopharma 12.1% Growth
Grifols awarded Gold Medal by EcoVadis for Sustainability Excellence
Grifols receives FDA approval to treat surgical bleeding in pediatric patients with its fibrin sealant solution
Grifols receives SBTi approval for its near-term science-based emission reduction targets
Grifols partners with BARDA for proof-of-concept testing of ocular immunoglobulin as treatment for sulfur mustard-induced eye injury
Grifols achieves its highest-ever score in the 2024 S&P Global Sustainability Assessment
GigaGen Awarded U.S. BARDA Contract to Develop Recombinant Polyclonal Antibody Therapies for Botulinum Neurotoxins and an Additional Biothreat
Thomas Glanzmann becomes non-executive Chairman
GigaGen Receives FDA Clearance of IND Application for Phase 1 Trial of Recombinant Polyclonal for HBV Treatment, GIGA-2339
Grifols Accelerates Performance in Q2 and Reaffirms Full Year Guidance
Grifols receives expanded XEMBIFY® (immune globulin subcutaneous human-klhw) label in U.S., strengthening its Ig portfolio for patients